MXPA05007348A - Derivados de polimeros solubles en agua tiol-selectivos. - Google Patents
Derivados de polimeros solubles en agua tiol-selectivos.Info
- Publication number
- MXPA05007348A MXPA05007348A MXPA05007348A MXPA05007348A MXPA05007348A MX PA05007348 A MXPA05007348 A MX PA05007348A MX PA05007348 A MXPA05007348 A MX PA05007348A MX PA05007348 A MXPA05007348 A MX PA05007348A MX PA05007348 A MXPA05007348 A MX PA05007348A
- Authority
- MX
- Mexico
- Prior art keywords
- thiol
- soluble
- derivatives
- polmer
- selective water
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G75/00—Macromolecular compounds obtained by reactions forming a linkage containing sulfur with or without nitrogen, oxygen, or carbon in the main chain of the macromolecule
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
- C07C319/06—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols from sulfides, hydropolysulfides or polysulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F22/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
- C08F22/36—Amides or imides
- C08F22/38—Amides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
- C08G65/2636—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G75/00—Macromolecular compounds obtained by reactions forming a linkage containing sulfur with or without nitrogen, oxygen, or carbon in the main chain of the macromolecule
- C08G75/20—Polysulfones
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Polyethers (AREA)
- Peptides Or Proteins (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Abstract
La presente invencion se refiere a derivados de polimeros solubles en agua, que tienen terminos tiolselectivos adecuados para acoplamiento selectivo a grupos tiol, tal como aquellos contenidos en los residuos cisteina de proteinas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43855503P | 2003-01-06 | 2003-01-06 | |
US45508403P | 2003-03-14 | 2003-03-14 | |
PCT/US2004/001190 WO2004063250A1 (en) | 2003-01-06 | 2004-01-06 | Thiol-selective water-soluble polmer derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05007348A true MXPA05007348A (es) | 2005-10-05 |
Family
ID=32717985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05007348A MXPA05007348A (es) | 2003-01-06 | 2004-01-06 | Derivados de polimeros solubles en agua tiol-selectivos. |
Country Status (10)
Country | Link |
---|---|
US (5) | US7910661B2 (es) |
EP (1) | EP1581582B2 (es) |
JP (1) | JP4490413B2 (es) |
KR (2) | KR101177340B1 (es) |
AT (1) | ATE485331T1 (es) |
AU (1) | AU2004204136B2 (es) |
CA (1) | CA2509939C (es) |
DE (1) | DE602004029646D1 (es) |
MX (1) | MXPA05007348A (es) |
WO (1) | WO2004063250A1 (es) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE444984T1 (de) * | 2002-12-31 | 2009-10-15 | Nektar Therapeutics Al Corp | Hydrolysestabile maleimidendgruppen-enthaltende polymere |
US7432331B2 (en) | 2002-12-31 | 2008-10-07 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
KR101177340B1 (ko) | 2003-01-06 | 2012-08-30 | 넥타르 테라퓨틱스 | 티올-선택성 수용성 중합체 유도체 |
EP2572732A1 (en) * | 2003-02-26 | 2013-03-27 | Nektar Therapeutics | Polymer-factor VIII moiety conjugates |
AU2005222641B2 (en) | 2004-03-15 | 2011-04-07 | Nektar Therapeutics | Polymer-based compositions and conjugates of HIV entry inhibitors |
SI3130601T1 (sl) | 2004-11-12 | 2020-11-30 | Bayer Healthcare Llc | Usmerjena modifikacija FVIII |
MX2007007471A (es) | 2004-12-21 | 2007-07-20 | Nektar Therapeutics Al Corp | Reactivos de tiol polimericos estabilizados. |
US8273339B2 (en) * | 2005-04-12 | 2012-09-25 | Nektar Therapeutics | Polymer-based compositions and conjugates of antimicrobial agents |
ATE425204T1 (de) * | 2005-08-26 | 2009-03-15 | Novo Nordisk As | Verfahren zur modifizierung eines makromolekularen systems |
WO2007075534A2 (en) | 2005-12-16 | 2007-07-05 | Nektar Therapeutics Al, Corporation | Polymer conjugates of glp-1 |
US7743730B2 (en) * | 2005-12-21 | 2010-06-29 | Lam Research Corporation | Apparatus for an optimized plasma chamber grounded electrode assembly |
JP2007209543A (ja) * | 2006-02-09 | 2007-08-23 | Hidetoshi Tsuchida | 表面修飾アルブミンからなる固相膜および酸素吸着膜 |
JP5312050B2 (ja) * | 2006-02-21 | 2013-10-09 | ネクター セラピューティクス | 分割型の分解性重合体とそれから生成される複合体 |
CA2648582C (en) | 2006-04-07 | 2016-12-06 | Nektar Therapeutics Al, Corporation | Conjugates of an anti-tnf-alpha antibody |
KR100819064B1 (ko) * | 2006-12-19 | 2008-04-04 | (재)대구경북과학기술연구원 | 생분자 고정화 링커 |
MX2010001955A (es) * | 2007-08-20 | 2010-03-10 | Enzon Pharmaceuticals Inc | Enlazadores polimericos que contienen porciones de disulfuro-piridilo. |
US7847019B2 (en) * | 2007-10-15 | 2010-12-07 | California Institute Of Technology | Functionalized polymers using protected thiols |
EP2095829A1 (en) | 2008-02-27 | 2009-09-02 | LEK Pharmaceuticals D.D. | Selenium containing modifying agents and conjugates |
UA101497C2 (ru) * | 2008-04-24 | 2013-04-10 | Селтик Фарма Пег Лтд. | Конъюгаты фактора ix с увеличенным временем полужизни |
CA2723821C (en) * | 2008-05-16 | 2017-05-02 | Nektar Therapeutics | Conjugates of a cholinesterase moiety and a polymer |
WO2009143412A2 (en) * | 2008-05-23 | 2009-11-26 | Enzon Pharmaceuticals, Inc. | Polymeric systems containing intracellular releasable disulfide linker for the delivery of oligonucleotides |
WO2010021720A1 (en) * | 2008-08-19 | 2010-02-25 | Nektar Therapeutics | Conjugates of small-interfering nucleic acids |
KR101660059B1 (ko) | 2008-08-22 | 2016-09-26 | 박스알타 인코퍼레이티드 | 중합체 벤질 카르보네이트-유도체 |
US20110165112A1 (en) * | 2008-09-19 | 2011-07-07 | Nektar Therapeutics | Polymer conjugates of c-peptides |
US20110171161A1 (en) * | 2008-09-19 | 2011-07-14 | Nektar Therapeutics | Polymer conjugates of protegrin peptides |
EP2334335A1 (en) * | 2008-09-19 | 2011-06-22 | Nektar Therapeutics | Polymer conjugates of cd-np peptides |
US20110171166A1 (en) * | 2008-09-19 | 2011-07-14 | Nektar Therapeutics | Polymer conjugates of osteocalcin peptides |
US20110171160A1 (en) * | 2008-09-19 | 2011-07-14 | Nektar Therapeutics | Polymer conjugates of kiss1 peptides |
WO2010033223A1 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of opioid growth factor peptides |
EP2340046A2 (en) * | 2008-09-19 | 2011-07-06 | Nektar Therapeutics | Polymer conjugates of ziconotide peptides |
EP2334333A1 (en) * | 2008-09-19 | 2011-06-22 | Nektar Therapeutics | Polymer conjugates of v681-like peptides |
US20110171164A1 (en) * | 2008-09-19 | 2011-07-14 | Nektar Therapeutics | Polymer conjugates of glp-2-like peptides |
WO2010033227A1 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of thymosin alpha 1 peptides |
WO2010033207A1 (en) | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides |
WO2010033220A2 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Modified therapeutics peptides, methods of their preparation and use |
US20110237524A1 (en) * | 2008-09-19 | 2011-09-29 | Nektar Therapeutics | Polymer conjugates of aod-like peptides |
US20110318322A1 (en) | 2009-01-12 | 2011-12-29 | Nektar Therapeutics | Conjugates of a Lysosomal Enzyme Moiety and a Water Soluble Polymer |
WO2012065086A1 (en) | 2010-11-12 | 2012-05-18 | Nektar Therapeutics | Conjugates of an il-2 moiety and a polymer |
US9783571B2 (en) | 2011-04-05 | 2017-10-10 | Warham Lance Martin | Isolation of cysteine containing peptides |
TWI597065B (zh) | 2011-06-10 | 2017-09-01 | 梅爾莎納醫療公司 | 蛋白質-聚合物-藥物共軛體 |
US8815226B2 (en) | 2011-06-10 | 2014-08-26 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
WO2013020079A2 (en) | 2011-08-04 | 2013-02-07 | Nektar Therapeutics | Conjugates of an il-11 moiety and a polymer |
CN104870020A (zh) | 2012-10-19 | 2015-08-26 | 康奈尔大学 | 用于关节软骨的仿生型界面润滑剂 |
JP6661073B2 (ja) * | 2013-10-04 | 2020-03-11 | 学校法人東京薬科大学 | 新規化合物、その製造方法及びその用途 |
CN115068626A (zh) | 2013-10-11 | 2022-09-20 | 阿萨纳生物科技有限责任公司 | 蛋白-聚合物-药物缀合物 |
EP3054991B1 (en) | 2013-10-11 | 2019-04-03 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
GB201401133D0 (en) | 2014-01-23 | 2014-03-12 | Renephra Ltd | Fluid extraction device, applicator device and associated methods |
EP3114138B1 (en) | 2014-03-05 | 2021-11-17 | Pfizer Inc. | Improved muteins of clotting factor viii |
MA39711A (fr) | 2014-04-03 | 2015-10-08 | Nektar Therapeutics | Conjugués d'une fraction d'il-15 et d'un polymère |
WO2016074030A1 (en) * | 2014-11-10 | 2016-05-19 | Spinal Developments Pty Ltd, A.T.F. The Spinesr Unit Trust | Rod reduction device |
US20160151511A1 (en) | 2014-12-02 | 2016-06-02 | Antriabio, Inc. | Proteins and protein conjugates with increased hydrophobicity |
AU2016270302B2 (en) | 2015-06-04 | 2020-09-17 | Rezolute, Inc. | Amine pegylation methods for the preparation of site-specific protein conjugates |
LT3463308T (lt) | 2016-06-01 | 2022-02-10 | Servier IP UK Limited | Polialkilenoksido-asparaginazės vaisto formos ir jų gamybos būdai bei panaudojimas |
CN107952064B (zh) * | 2016-10-14 | 2023-10-20 | 江苏豪森药业集团有限公司 | 含有聚乙二醇洛塞那肽的药物制剂及其制备方法 |
EP3604386B1 (en) * | 2017-03-30 | 2022-04-06 | NOF Corporation | Degradable polyethylene glycol derivative having disulfide linker |
GB201721503D0 (en) | 2017-12-20 | 2018-01-31 | Univ Essex | Modified globin proteins |
CA3128035A1 (en) | 2020-08-13 | 2022-02-13 | Bioasis Technologies, Inc. | Combination therapies for delivery across the blood brain barrier |
AT524137A2 (de) | 2020-08-26 | 2022-03-15 | Pke Holding Ag | Tragbare Vorrichtung zur Steuerung eines Brandfalles |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB707709A (en) † | 1951-04-02 | 1954-04-21 | Albert Boehringer | Process for the production of n-[-a:-g-dihydroxy--a:-a-dimethyl-butyryl]--a-alanine--a-mercaptoethylamide |
US3005853A (en) † | 1959-06-22 | 1961-10-24 | California Research Corp | Preparation of mercaptan and sulfide derivatives thereof |
US3063971A (en) † | 1959-06-22 | 1962-11-13 | California Research Corp | Polygycol sulfide-linked block copolymers |
EP0040506B1 (en) † | 1980-05-21 | 1986-08-20 | Teijin Limited | Reactive polymer and process for the preparation thereof |
JPS5730724A (en) † | 1980-07-31 | 1982-02-19 | Teijin Ltd | Polymer having disulfide bond in molecule and its preparation |
JPS63230086A (ja) † | 1987-03-17 | 1988-09-26 | Nitto Electric Ind Co Ltd | 生理活性物質固定用担体 |
US4958368A (en) † | 1988-10-31 | 1990-09-18 | Gte Mobilnet Incorporated | Customer activation system |
US5135866A (en) † | 1989-03-03 | 1992-08-04 | W. R. Grace & Co.-Conn. | Very low protein nutrient medium for cell culture |
US5516703A (en) | 1993-08-20 | 1996-05-14 | The University Of Utah | Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands |
WO1994027498A1 (en) † | 1993-05-20 | 1994-12-08 | The Regents Of The University Of California | Macromolecular contrast media for mr imaging |
US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
US5741715A (en) * | 1995-05-30 | 1998-04-21 | Roche Diagnostic Systems, Inc. | Quinidine immunoassay and reagents |
US5672662A (en) * | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
TW520297B (en) † | 1996-10-11 | 2003-02-11 | Sequus Pharm Inc | Fusogenic liposome composition and method |
AU9187498A (en) † | 1997-10-03 | 1999-04-27 | Star Micronics Co., Ltd. | Image formation apparatus, image formation methods and plate making method |
WO1999018069A1 (fr) † | 1997-10-03 | 1999-04-15 | Star Micronics Co., Ltd. | Derives d'acide maleique, intermediaires de derives d'acide maleique, et leurs procedes de preparation |
US6258774B1 (en) | 1998-03-19 | 2001-07-10 | University Of Medicine And Dentistry Of New Jersey | Carrier for in vivo delivery of a therapeutic agent |
US6495136B1 (en) * | 1998-03-26 | 2002-12-17 | The Procter & Gamble Company | Proteases having modified amino acid sequences conjugated to addition moieties |
JP3880262B2 (ja) † | 1998-11-02 | 2007-02-14 | 株式会社カネカ | 水不溶化再生コラーゲン繊維の製造方法 |
AU5376500A (en) * | 1999-06-17 | 2001-01-09 | Universiteit Gent | Functional poly-alpha-aminoacid derivatives useful for the modification of biologically active materials and their application |
WO2001007013A2 (en) † | 1999-07-22 | 2001-02-01 | University Of Medicine And Dentistry Of New Jersey | Thioamide moiety-containing polymer drug conjugates |
US6413507B1 (en) | 1999-12-23 | 2002-07-02 | Shearwater Corporation | Hydrolytically degradable carbamate derivatives of poly (ethylene glycol) |
KR100346994B1 (ko) † | 2000-01-11 | 2002-07-31 | 한국과학기술연구원 | 술폰산화 폴리에틸렌옥사이드가 결합된 생체적합성 의료용금속 재료 및 이의 제조 방법 |
TW593427B (en) | 2000-12-18 | 2004-06-21 | Nektar Therapeutics Al Corp | Synthesis of high molecular weight non-peptidic polymer derivatives |
ATE444984T1 (de) * | 2002-12-31 | 2009-10-15 | Nektar Therapeutics Al Corp | Hydrolysestabile maleimidendgruppen-enthaltende polymere |
CA2509260C (en) * | 2002-12-31 | 2012-10-02 | Nektar Therapeutics Al, Corporation | Maleamic acid polymer derivatives and their bioconjugates |
KR101177340B1 (ko) * | 2003-01-06 | 2012-08-30 | 넥타르 테라퓨틱스 | 티올-선택성 수용성 중합체 유도체 |
-
2004
- 2004-01-06 KR KR1020057012633A patent/KR101177340B1/ko active IP Right Grant
- 2004-01-06 KR KR1020117031376A patent/KR101207247B1/ko active IP Right Grant
- 2004-01-06 AU AU2004204136A patent/AU2004204136B2/en not_active Expired
- 2004-01-06 EP EP04700409.8A patent/EP1581582B2/en not_active Expired - Lifetime
- 2004-01-06 US US10/753,047 patent/US7910661B2/en active Active
- 2004-01-06 DE DE602004029646T patent/DE602004029646D1/de not_active Expired - Lifetime
- 2004-01-06 CA CA2509939A patent/CA2509939C/en not_active Expired - Lifetime
- 2004-01-06 WO PCT/US2004/001190 patent/WO2004063250A1/en active Application Filing
- 2004-01-06 JP JP2006500996A patent/JP4490413B2/ja not_active Expired - Lifetime
- 2004-01-06 AT AT04700409T patent/ATE485331T1/de not_active IP Right Cessation
- 2004-01-06 MX MXPA05007348A patent/MXPA05007348A/es active IP Right Grant
-
2010
- 2010-10-21 US US12/909,755 patent/US20110034643A1/en not_active Abandoned
-
2012
- 2012-11-19 US US13/681,357 patent/US8722032B2/en not_active Expired - Lifetime
-
2014
- 2014-03-28 US US14/229,547 patent/US9040658B2/en not_active Expired - Lifetime
-
2015
- 2015-04-23 US US14/694,160 patent/US9333267B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20140330041A1 (en) | 2014-11-06 |
US9040658B2 (en) | 2015-05-26 |
US20050014903A1 (en) | 2005-01-20 |
ATE485331T1 (de) | 2010-11-15 |
WO2004063250A1 (en) | 2004-07-29 |
DE602004029646D1 (en) | 2010-12-02 |
KR20120007080A (ko) | 2012-01-19 |
KR101177340B1 (ko) | 2012-08-30 |
US9333267B2 (en) | 2016-05-10 |
CA2509939C (en) | 2013-05-21 |
US7910661B2 (en) | 2011-03-22 |
CA2509939A1 (en) | 2004-07-29 |
EP1581582A1 (en) | 2005-10-05 |
AU2004204136A1 (en) | 2004-07-29 |
US20110034643A1 (en) | 2011-02-10 |
AU2004204136B2 (en) | 2008-10-09 |
EP1581582B1 (en) | 2010-10-20 |
JP2006517600A (ja) | 2006-07-27 |
JP4490413B2 (ja) | 2010-06-23 |
KR101207247B1 (ko) | 2012-12-03 |
KR20050090074A (ko) | 2005-09-12 |
US20130079555A1 (en) | 2013-03-28 |
US20150224207A1 (en) | 2015-08-13 |
US8722032B2 (en) | 2014-05-13 |
EP1581582B2 (en) | 2017-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05007348A (es) | Derivados de polimeros solubles en agua tiol-selectivos. | |
HK1173169A1 (en) | Dimercaptan terminated polythioether polymers and methods for making and using the same | |
HK1210627A1 (en) | Preparing crude biological estracts using protease, suitable for preparing cdna cdna | |
WO2004082622A3 (en) | Retinoid replacements and opsin agonists and methods for the use thereof | |
GEP20074016B (en) | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | |
WO2007092829A3 (en) | Stabilized compositions of proteins having a free thiol moiety | |
WO2006128685A3 (en) | Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions | |
NO20090047L (no) | Anti-DLL4-antistoffer og fremgangsmater for anvendelse av disse | |
WO2006083275A3 (en) | Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof | |
WO2005087793A3 (en) | Immunostimulatory compositions and uses thereof | |
CA2597065C (en) | Compositions and methods related to soluble g-protein coupled receptors (sgpcrs) | |
WO2007136893A3 (en) | Anti-fgf19 antibodies and methods using same | |
AU2002350592A1 (en) | Ph-sensitive polymer | |
WO2007028110A3 (en) | Methods for using and identifying modulators of delta-like 4 | |
EP2202310A3 (en) | Caustic stable chromatography ligands | |
NO20043245L (no) | Bindingsproteiner som biosensorer | |
ATE494012T1 (de) | Stabilisierte polymer-thiol-reagenzien | |
DE602006018856D1 (de) | Neue nutrazeutika-zusammensetzungen | |
BR0211617A (pt) | Partìculas inorgânicas e métodos de fabricação | |
WO2007075438A3 (en) | Polypeptides comprising unnatural amino acids, methods for their production and uses therefor | |
WO2005047471A3 (en) | Improved fret efficiency methods | |
WO2006127011A8 (en) | Emulsions of ionic liquids | |
WO2005116252A8 (en) | Methods for evaluating ribonucleotide sequences | |
WO2008094945A3 (en) | Compounds and methods for modulating protein expression | |
WO2005086654A3 (en) | Self-cleaving affinity tags and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights | ||
FG | Grant or registration |